Cite

A <italic>de novo</italic> loss‐of‐function <italic>DYNC1H1</italic> mutation in a patient with parkinsonian features and a favourable response to levodopa.

MLA

Szczałuba, K., et al. “A de Novo Loss‐of‐function DYNC1H1 Mutation in a Patient with Parkinsonian Features and a Favourable Response to Levodopa.” Clinical Genetics, vol. 93, no. 5, May 2018, pp. 1107–08. EBSCOhost, https://doi.org/10.1111/cge.13133.



APA

Szczałuba, K., Rydzanicz, M., Walczak, A., Kosińska, J., Jacoszek, A., Biernacka, A., Gasperowicz, P., Płoski, R., Szymańska, K., Ciara, E., Piekutowska, A. D., Pronicka, E., Czerska, K., & Laure, K. M. (2018). A de novo loss‐of‐function DYNC1H1 mutation in a patient with parkinsonian features and a favourable response to levodopa. Clinical Genetics, 93(5), 1107–1108. https://doi.org/10.1111/cge.13133



Chicago

Szczałuba, K., M. Rydzanicz, A. Walczak, J. Kosińska, A. Jacoszek, A. Biernacka, P. Gasperowicz, et al. 2018. “A de Novo Loss‐of‐function DYNC1H1 Mutation in a Patient with Parkinsonian Features and a Favourable Response to Levodopa.” Clinical Genetics 93 (5): 1107–8. doi:10.1111/cge.13133.